Tirzepatide
₹159.00
A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.
- Purity
- ≥99%
- Mol. weight
- 4813.5 g/mol
- CAS
- 2023788-19-2
- Form
- Lyophilized powder
- HPLC verified
- Batch COA
- Cold-packed
- Ships in 24h
SKU: PEP-TIRZ
- Product Overview
- Description
- Research Applications
- Mechanism of Action
- Key Research Benefits
- Studies
A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.
Tirzepatide is supplied at ≥99% purity as verified by HPLC, with identity confirmed by mass spectrometry. Every vial is labelled with a lot number traceable to its Certificate of Analysis.
Information provided for laboratory research reference only.
Description
A dual GIP and GLP-1 receptor agonist peptide investigated in metabolic research.
Each lot is synthesised by solid-phase peptide synthesis, purified by preparative HPLC and released only after independent analytical testing. Supplied as a lyophilized powder in a sealed glass vial.
For laboratory research use only. Not for human or veterinary use.
Tirzepatide is used by investigators in the following research areas:
- Dual incretin receptor research
- Insulin secretion assays
- Lipid metabolism models
Information provided for laboratory research reference only.
Tirzepatide is a 39-amino-acid peptide engineered to activate both GIP and GLP-1 receptors. A C20 fatty-diacid moiety supports albumin binding and prolonged activity in research models.
Information provided for laboratory research reference only.
- Dual-receptor activity in one compound
- Extended half-life
- Batch-level identity confirmation by MS
Information provided for laboratory research reference only.
Tirzepatide has been examined in a body of peer-reviewed preclinical literature. Researchers should consult primary sources for study design, models and findings.
Referenced literature is provided for scientific context only and does not imply suitability for any use outside the laboratory.
Information provided for laboratory research reference only.
Compound Information
Chemical identity and handling data
| Molecular formula | C225H348N48O68 |
|---|---|
| Molecular weight | 4813.5 g/mol |
| CAS number | 2023788-19-2 |
| Purity | ≥99% |
| Amount per vial | 10 mg |
| Form | Lyophilized powder |
| Appearance | White to off-white powder |
| Solubility | Water, bacteriostatic water |
| Storage | -20°C, desiccated, protected from light |
| Peptide class | GIP/GLP-1 dual agonist |
Certificate of Analysis
Independent batch testing results
Every batch is independently tested. Match the lot number printed on your vial with the certificate below.
- Purity
- 99.50%
- Tested
- July 10, 2026
- Method
- HPLC / ESI-MS
- Mass
- 4813.5 Da
Reconstitution Calculator
Plan concentration and syringe units for this vial
Calculators are provided for laboratory research planning only and do not constitute medical advice.
Frequently Asked Questions
Handling, storage and documentation
Q01How should Tirzepatide be stored?
Store the lyophilized vial at -20°C, protected from light and moisture. After reconstitution, keep refrigerated at 2–8°C and use within the timeframe appropriate to your protocol.
Q02How do I reconstitute the vial?
Allow the vial to reach room temperature, then slowly add bacteriostatic water down the side of the vial and swirl gently — do not shake. Use our reconstitution calculator to plan concentrations.
Q03Where can I find the COA for my vial?
Match the lot number printed on your vial label with the certificate in the COA tab or in our COA library.
Researcher Reviews
Feedback from verified buyers
Related research compounds
-
-
Semaglutide
- Purity
- ≥99%
- MW
- 4113.6 g/mol
- CAS
- 910463-68-2
₹89.00 – ₹149.00Price range: ₹89.00 through ₹149.00View Data Select options This product has multiple variants. The options may be chosen on the product page



Reviews
There are no reviews yet.